These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

448 related articles for article (PubMed ID: 18952090)

  • 1. Progesterone reduces the effect of the serotonin 1B/1D receptor antagonist, GR 127935, on lordosis behavior.
    Uphouse L; Hiegel C; Guptarak J; Maswood N
    Horm Behav; 2009 Jan; 55(1):169-74. PubMed ID: 18952090
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progesterone attenuates the effect of the 5-HT1A receptor agonist, 8-OH-DPAT, and of mild restraint on lordosis behavior.
    Truitt W; Harrison L; Guptarak J; White S; Hiegel C; Uphouse L
    Brain Res; 2003 Jun; 974(1-2):202-11. PubMed ID: 12742638
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tropisetron increases the inhibitory effect of mild restraint on lordosis behavior of hormonally primed, ovariectomized rats.
    Uphouse L; Heckard D; Hiegel C; Guptarak J; Maswood S
    Behav Brain Res; 2011 Jun; 219(2):221-6. PubMed ID: 21238491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serotonin receptor involvement in effects of restraint on female rat lordosis behavior.
    Uphouse L; Hiegel C; Perez E; Guptarak J
    Pharmacol Biochem Behav; 2007 Apr; 86(4):631-6. PubMed ID: 17368527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Restraint accentuates the effects of 5-HT2 receptor antagonists and a 5-HT1A receptor agonist on lordosis behavior.
    Uphouse L; White S; Harrison L; Hiegel C; Majumdar D; Guptarak J; Truitt WA
    Pharmacol Biochem Behav; 2003 Aug; 76(1):63-73. PubMed ID: 13679218
    [TBL] [Abstract][Full Text] [Related]  

  • 6. WAY100635 and female rat lordosis behavior.
    Uphouse L; Wolf A
    Brain Res; 2004 Jul; 1013(2):260-3. PubMed ID: 15193537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of estrogen on the lordosis-inhibiting action of ketanserin and SB 206553.
    Sinclair-Worley L; Uphouse L
    Behav Brain Res; 2004 Jun; 152(1):129-35. PubMed ID: 15135976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MK-801 infusions to the ventral tegmental area and ventromedial hypothalamus produce opposite effects on lordosis of hormone-primed rats.
    Petralia SM; DeBold JF; Frye CA
    Pharmacol Biochem Behav; 2007 Feb; 86(2):377-85. PubMed ID: 17292951
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 5-HT3 receptors in the ventromedial nucleus of the hypothalamus and female sexual behavior.
    Maswood N; Caldarola-Pastuszka M; Uphouse L
    Brain Res; 1997 Sep; 769(1):13-20. PubMed ID: 9374268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors elevating cAMP attenuate the effects of 8-OH-DPAT on lordosis behavior.
    Uphouse L; Maswood S; Jackson A
    Pharmacol Biochem Behav; 2000 Jun; 66(2):383-8. PubMed ID: 10880694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced efficacy of 8-OH-DPAT's inhibition of lordosis behavior by prior estrogen treatment.
    Trevino A; Wolf A; Jackson A; Price T; Uphouse L
    Horm Behav; 1999 Jun; 35(3):215-23. PubMed ID: 10373334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogen and progesterone dose-dependently reduce disruptive effects of restraint on lordosis behavior.
    White S; Uphouse L
    Horm Behav; 2004 Mar; 45(3):201-8. PubMed ID: 15047015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prior hormonal treatment, but not sexual experience, reduces the negative effects of restraint on female sexual behavior.
    Uphouse L; Hiegel C; Adams S; Murillo V; Martinez M
    Behav Brain Res; 2014 Feb; 259():35-40. PubMed ID: 24172220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progesterone reduces the inhibitory effect of a serotonin 1B receptor agonist on lordosis behavior.
    Uphouse L; Guptarak J; Hiegel C
    Pharmacol Biochem Behav; 2010 Dec; 97(2):317-24. PubMed ID: 20816890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen-progesterone and 8-OH-DPAT attenuate the lordosis-inhibiting effects of the 5-HT1A agonist in the VMN.
    Uphouse L; Caldarola-Pastuszka M; Maswood S; Andrade M; Moore N
    Brain Res; 1994 Feb; 637(1-2):173-80. PubMed ID: 8180795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. GABAA-5-HT1A receptor interaction in the mediobasal hypothalamus.
    Guptarak J; Selvamani A; Uphouse L
    Brain Res; 2004 Nov; 1027(1-2):144-50. PubMed ID: 15494165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of mianserin and ketanserin on lordosis behavior after systemic treatment or infusion into the ventromedial nucleus of the hypothalamus.
    Uphouse L; Colon L; Cox A; Caldarola-Pastuszka M; Wolf A
    Brain Res; 1996 Apr; 718(1-2):46-52. PubMed ID: 8773765
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of mu-opioid receptors inhibits lordosis behavior in estrogen and progesterone-primed female rats.
    Acosta-Martinez M; Etgen AM
    Horm Behav; 2002 Feb; 41(1):88-100. PubMed ID: 11863387
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Facilitation of female rat lordosis behavior by hypothalamic infusion of 5-HT(2A/2C) receptor agonists.
    Wolf A; Caldarola-Pastuszka M; Uphouse L
    Brain Res; 1998 Jan; 779(1-2):84-95. PubMed ID: 9473601
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms responsible for progesterone's protection against lordosis-inhibiting effects of restraint I. Role of progesterone receptors.
    Hassell J; Miryala CS; Hiegel C; Uphouse L
    Horm Behav; 2011 Jul; 60(2):219-25. PubMed ID: 21635894
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.